CAI
Caris Life Sciences
201 hedge funds and large institutions have $2.8B invested in Caris Life Sciences in 2026 Q1 according to their latest regulatory filings, with 57 funds opening new positions, 88 increasing their positions, 38 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
20% less call options, than puts
Call options by funds: $4.57M | Put options by funds: $5.71M
29% less capital invested
Capital invested by funds: $3.92B → $2.8B (-$1.12B)
29% less funds holding in top 10
Funds holding in top 10: 7 → 5 (-2)
Holders
201
Holding in Top 10
5
Calls
$4.57M
Puts
$5.71M
Top Buyers
| 1 | +$362M | |
| 2 | +$54.3M | |
| 3 | +$50M | |
| 4 |
DFO
Duquesne Family Office
New York
|
+$41.4M |
| 5 |
Capital World Investors
Los Angeles,
California
|
+$25.8M |
Top Sellers
| 1 | -$109M | |
| 2 | -$79.1M | |
| 3 | -$66.4M | |
| 4 |
Millennium Management
New York
|
-$46.4M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$44.8M |
